Carcinoma cell mitochondria preferentially accumulate and retain certain cationic dyes to a much greater extent than most normal cells. Thus, they can potentially serve as targets for highly selective photochemotherapy. We evaluated 10 rhodamine and cyanine dyes as carcinoma-specific mitochondrial photosensitizers in vitro. The most effective,
Cancer therapies depend on preferentially killing malignant cells, and approaches that selectively damage carcinoma cells are of great interest. Rather than relying on the specificity of drug action alone, the approach of photochemotherapy employs photosensitizing molecules that preferentially localize in target cells and are relatively innocuous in the absence of light. Illumination causes the production of toxic or reactive species that kill the cells. Spatial confinement of the irradiation to the vicinity of the tumor cells imparts dual selectivity, since damage requires the simultaneous presence of photosensitizer and light. Hematoporphyrin derivative (HPD), the most commonly employed photosensitizer, has been useful for various cancers (1) (2) (3) . However, HPD, which is a negatively charged molecule, shows little selectivity in vitro (4) , and its mechanisms of phototoxicity and sites of photodamage have not been fully defined (5) (6) (7) .
Positively charged, lipophilic dyes can concentrate across membrane potentials into mitochondria; up to a 10,000-fold concentration gradient is theoretically possible (8) . Recently, Chen and his associates demonstrated that carcinoma cell mitochondria take up higher concentrations of membranepermeable, cationic molecules such as rhodamine 123 (Rh 123) and retain them much longer than most normal cells (8) (9) (10) (11) . Although brief incubations with Rh 123 are innocuous (9) , with prolonged exposures the dye is preferentially toxic to carcinoma cells (10) (11) (12) . Thus, cationic dyes may serve as carcinoma cell-specific therapeutic agents (10) (11) (12) (13) .
We postulated that preferential intramitochondrial retention of low levels of cationic photosensitizers might permit very selective killing of carcinoma cells under conditions in which there were minimal effects from the photosensitizer in the absence of light. This report demonstrates the feasibility of selective carcinoma cell photolysis (SCCP) in vitro, for human squamous, bladder, and colon carcinoma cells, using long-wavelength-absorbing dyes.
METHODS
Cationic Dyes. Rh 123, Rh 6G, 1,1',3,3,3',3'-hexamethylindodicarbocyanine iodide, 3,3'-diethyloxadicarbocyanine iodide, and 3,3'-diethyloxatricarbocyanine iodide were purchased from Eastman Kodak. Rh 123-(Br)4 was a kind gift of M. Hogan (Princeton University).
The symmetrical carbocyanines, N,N'-bis(2-ethyl-1,3-dioxolane)kryptocyanine (EDKC) and 3,3'-bis(ethylvalerate) thiacarbocyanine bromide, were prepared by the method of Hamer (14) , as illustrated by the synthesis of EDKC. In brief, 1-(2-ethylene-1,3-dioxolane)-4-methylquinolinium bromide (0.66 g, 2 mmol) and 6 ml of dry pyridine were stirred at 110°C under a nitrogen atmosphere until solution occurred. To this was added 0.75 g (5 mmol) of triethylorthoformate and stirring was continued for 2 hr. The deep cyan colored solution was cooled and poured into rapidly stirred ethyl ether (200 ml). The crude product was isolated by filtration and was purified by medium-pressure column chromatography (Woelm 32-63 silica gel, methylene chloride/methanol). The fractions that were homogeneous by TLC analysis (silica gel, 5% methanol/methylene chloride) were combined to give 0.10 g (17%) of a purple/blue solid.
To prepare 1-(2-ethylene-1,3-dioxolane)-4-methylquinolinium bromide, a mixture of 4-methylquinoline (1.43 g, 0.010 mol) and 2-(2-bromoethyl)-1,3-dioxolane (2.0 g, 0.011 mol) was stirred at 120°C under a nitrogen atmosphere for 3 hr. The viscous reaction mixture was cooled and triturated several times with ethyl ether, leaving the product as a tan solid. The crude product was purified by medium-pressure chromatography (Woelm 32-63 silica gel, methylene chloride/methanol) to yield 1.7 g (50%) of a white solid. The product was homogeneous by TLC (silica gel, 5% methanol/methylene chloride).
The symmetrical tricarbocyanine 1,1'-bis(3-propylamine hydrochloride)-3 ,3 ,3',3 '-tetramethylindotricarbocyanine bromide was prepared by established methods (15) . 1-(3-Propylamine hydrobromide)-2,3,3'-trimethylindoline bromide (2.6 g, 6.8 mmol) and 50 ml of dry pyridine were stirred at reflux under a nitrogen atmosphere until solution occurred. To this was added 1-(4-pyridyl)pyridinium chloride hydrochloride (0.80 g, 3.4 mmol) and stirring was continued for 3 hr. The cyan-colored mixture was cooled and the pyridine was decanted from the solid. Acetone was added to the flask and stirred well and the dye was isolated by filtration. The crude product was crystallized from 30 ml of ethanol to yield 0.30 g (12%) of metallic green crystals: TLC analysis (silica gel, 5% methanol/methylene chloride) one spot; visible (MeOH), 747 nm.
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The unsymmetrical 4,4'-carbocyanine 1-(3-propylamine hydrobromide)-1-(3-sulfopropyl)kryptocyanine was prepared by using the modified methods ofHamer (16) and Ogata (17 RESULTS AND DISCUSSION Dye Selection. We evaluated the phototoxicity of 10 cationic dyes on the EJ (MGH-U1) human bladder carcinoma cell line. The dyes included Rh 6G, Rh 123, and Rh 123-(Br)4, in which the bromine substitutions increase the photosensitization efficiency (21) , as well as cyanine dyes that absorb at wavelengths >600 nm. By selecting photosensitizers with strong absorbance within the 600-to 1200-nm "therapeutic window" where tissue light scattering is low and there is little competing absorption from endogenous biomolecules such as hemoglobin, melanin, and water, it is possible to achieve light penetration many millimeters into tissue (22) , making photochemotherapy potentially feasible for many clinically important tumors.
The results of this initial screen are summarized in Fig. 1 , which compares dark-and light-induced carcinoma cell Proc. Natl. Acad. Sci. USA 83 (1986) killing. Except for the highest concentration of Rh 6G, the rhodamines were essentially nontoxic without light, as reported for short incubations (9) . Neither Rh 6G nor Rh 123 was significantly phototoxic. Rh 123-(Br)4 was also relatively ineffective, despite its capacity to produce singlet oxygen (21) .
The most effective photosensitizer with low dark toxicity at the doses used was EDKC. This molecule has desirable spectral properties, with a high extinction coefficient and a solvent-dependent absorption maximum near 700 nm (Fig. 2) .
EDKC is preferentially accumulated in carcinoma cells (Table 1) , with >60% of the dye still present after 48 hr. In contrast, normal human keratinocytes and CV-1 cells, a normal epithelial cell line derived from the African green monkey kidney, accumulated little dye (Table 1 ) and released it within 2 hr. After a 30-min incubation with 1 AM EDKC, there was a 300-fold concentration of dye into EJ cells. The absorption maximum of EDKC within suspensions of EJ cells was 714 nm, suggesting that the dye was not in a simple aqueous environment within the cells.
As in the case of Rh 123 (10-12), the dark toxicity of EDKC depended on dye dose and incubation time and was somewhat greater for the carcinoma cell lines tested than for the noncarcinoma cells. For 30-min incubations at 0.1 AM in a colony-forming assay, there was a 13% ± 5% (mean ± SEM, four determinations) decrease in EJ survival, compared with a 4% ± 2% decrease in CV-1 survival. EDKC dosages were generally chosen to give <15% dark toxicity for the carcinoma cells.
EDKC showed a remarkable difference in phototoxicity between EJ and CV-1 cells, as shown qualitatively in the photomicrographs depicting the boundary zone (without light/with light) for each cell type (Fig. 3) . EJ cells exposed to dye alone (Fig. 3 Left, lower half) were essentially unaffected, whereas addition of light eliminated almost all of the cells. In contrast, the CV-1 cells on either side of the boundary appear identical. Similar differences between carcinoma and noncarcinoma cells were obtained for the other cell types examined in this study.
EDKC phototoxicity was quantified by a clonogenic assay and by measuring the number of cells excluding ethidium bromide 18 hr after irradiation. J/cm2), there was greatly decreased capacity for mitochondrial Rh 123 uptake, with only faint, diffuse cytoplasmic fluorescence apparent. However, there was no nuclear uptake of ethidium bromide. After (26) and nucleus (21, 27) , cannot be completely excluded. The biochemical basis for the preferential mitochondrial uptake .*.' 6, O. or and retention of EDKC by carcinoma cells and the consequential selective phototoxicity has not been clearly established. Recent evidence suggests that at least part of this process may be due to differences in mitochondrial and/or plasma membrane potentials in carcinoma cells (8, 20, 25) .
The relatively high light doses required for cell killing suggest that the efficiency of intracellular photodamage is low. This is in agreement with solution studies that find the quantum yields for EDKC photolysis are on the order of 10-(28). In addition, however, the relatively large fluence may be due to the fact that with 0.1 ,M incubations, the incorporated EDKC is only on the order of 10-14 g per cell. In typical experiments with HPD, which required about 2 J/cm2 to kill 90% of the cells, on the order of 10-12 g of HPD was incorporated per cell (29) .
The dark toxicity of EDKC in this study may be due to inhibition of mitochondrial function to a level that still permits survival of the majority of the cells. For 0.1 1LM dye, the carcinoma cells incorporated on the order of 0.1 ,umol of EDKC per g of mitochondrial protein, assuming that the cell volume is about 4 x 10-9 cm3 and the mitochondria constitute 10-20% of the cell volume. Comparable levels of a related molecule, 1,1'-diethyl-4,4'-carbocyanine, substantially inhibited respiration in isolated rat liver mitochondria (30) . However, in preliminary experiments in vivo, BALB/c and nude mice have tolerated systemic administration of 5-50 mg/kg doses of cationic photosensitizers that preferentially localize at tumor sites (data not shown).
CONCLUSIONS SCCP combines preferential uptake and retention of cationic photosensitizers by carcinoma cells (Table 1) with the additional specificity made possible by controlled illumination (Fig. 3) . This study confirms and extends previous findings that cationic dyes can preferentially accumulate within carcinoma cells (8, 9, 25) and demonstrates that highly selective, light-induced mitochondrial damage and cell killing are possible after brief exposure to some of these dyes. An important aspect of this work is that the photolysis depends only on two relatively "generic" properties: mitochondrial accumulation and photosensitization. Thus, though EDKC was the most selective phototoxin in the group of dyes that we evaluated, it is possible that other cationic molecules that concentrate within mitochondria at higher levels or that are more efficient photosensitizers will be still more effective.
The marked in vitro selectivity for carcinoma cell killing with EDKC and the probable targeting of the photodamage to mitochondria distinguish SCCP from most chemotherapies, including photoradiation therapy with HPD, which shows little specificity for tumor cells in culture (4) and appears to have multiple, perhaps complementary, sites of action in vitro and in vivo (5) (6) (7) . Comparably high in vitro specificity for leukemia cell photolysis has been found for the noncationic, plasma membrane-binding dye merocyanine 540; however, this compound does not seem effective for carcinomas (31, 32) .
In addition to potential therapeutic applications, SCCP may be a useful technique for rapidly altering mitochondrial function and intracellular ATP levels. If it is used in vivo, the need for only brief exposures to low doses of mitochondrialselective dyes may minimize systemic toxicity compared to use of dyes alone (13) and may permit topical or intralesional dye administration.
